NCT00756977View on ClinicalTrials.gov

BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

394

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

November 30, 2008

Conditions
Colon Cancer
Interventions
DRUG

BLI850

multi-dose preparation for oral administration prior to colonoscopy

DRUG

polyethylene glycol 3350 based bowel preparation

multi-dose preparation for oral administration prior to colonoscopy

Trial Locations (12)

11023

Long Island GI Research Group, Great Neck

17604

Regional Gastroenterology Associates of Lancaster, Lancaster

20707

Maryland Digestive Disease Research, Laurel

27612

Wake Research Associates, Raleigh

28075

Carolina Digestive Health Associates, Harrisburg

30076

Atlanta Gastroenterology Associates, Roswell

32168

United Medical Research, New Smyrna Beach

33143

Miami Research Associates, Miami

33458

Jupiter Research, Jupiter

36693

University of South Alabama, Mobile

37403

Southeastern Clinical Research, Chattanooga

71201

Delta Research Partners, Monroe

Sponsors
All Listed Sponsors
lead

Braintree Laboratories

INDUSTRY